The SEC has halted Nasdaq’s launch of its cash-settled Bitcoin options product following a regulatory dispute with the CME Group. The Nasdaq Bitcoin index options, QBTC, were given conditional approval in May 2026 but now face suspension while the commission reconsiders jurisdiction. The SEC opened a public comment window until August 24 as the debate heats up over which agency should oversee Bitcoin derivatives.
CME argues that Bitcoin is a commodity, not a security, and therefore the Commodity Futures Trading Commission should have exclusive regulatory authority. Since CME already offers regulated Bitcoin futures and options under CFTC rules, it views Nasdaq’s product as bypassing the proper framework by going through the SEC. Nasdaq’s QBTC product references the Nasdaq Bitcoin Index, which is tied to CME’s own benchmark, creating direct competition on the institutional derivatives front.
Regulatory Turf War Unfolds
This isn’t just a technicality. The SEC’s conditional approval required CFTC exemptions before Nasdaq could launch QBTC, but CME’s challenge contends that such exemptions can’t simply move oversight between agencies. The full SEC commission is now reviewing the matter, delaying Nasdaq’s plans as the industry watches closely to see which regulator will claim Bitcoin derivatives jurisdiction.
The outcome impacts more than just these two giants. It will set a precedent for how Bitcoin cash-settled options are regulated in the U.S. and could influence the pace of innovation in cryptocurrency financial products. Meanwhile, major players jockey for position in a market segment expected to grow substantially over the coming years.
This material is for informational purposes only and does not constitute financial advice.
